Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    2 0 0 0

Revue du rhumatisme
Volume 79, n° 3
pages 282-283 (mai 2012)
Doi : 10.1016/j.rhum.2011.12.015
accepted : 6 December 2011
Évolution spectaculaire d’une arthrite réactionnelle après traitement précoce par infliximab

Marie Thomas-Pohl a, , Axelle Tissot b, Frédéric Banal b, Dominique Lechevalier b
a Service de médecine physique et de réadaptation, hôpital d’instruction des Armées Percy, 101, avenue Henri-Barbusse, 92141 Clamart cedex, France 
b Service de rhumatologie, hôpital d’instruction des Armées Bégin, 69, avenue de Paris, 94067 Saint-Mandé, France 

Auteur correspondant.

Mots clés : Arthrite réactionnelle, Infliximab, Traitement précoce

 Ne pas utiliser, pour citation, la référence française de cet article, mais la référence anglaise de Joint Bone Spine (doi:10.1016/j.jbspin.2012.03.001).

© 2012  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline